Oral Appliance Maker ProSomnus Reports Record Revenue for 2023
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
Sleep is as essential to our health as food and water. For World Sleep Day, experts to tell us more about this essential part of our lives.
The ultra-compact full-face mask is designed to offer the comfort of smaller masks without sacrificing performance.
The results were unexpected since Black people have been shown to have a higher risk of stroke and are more likely to have sleep apnea than white people, researchers say.
Read MoreThe project, supported by a $3 million NIH grant, also aims to identify patients who would benefit most from using CPAP, as well as patients who should avoid CPAP.
Read MoreA new study highlights the connection between the supine position and the specific endotypic characteristics that exacerbate obstructive sleep apnea.
Read MoreIn President Joe Biden’s recent annual physical, the most significant development was the...
Read MoreA preliminary study reveals an association between sleep apnea symptoms and increased likelihood of memory or thinking problems.
Read MoreWhile tonsil surgery is the primary treatment for OSA in children, medical literature and affected families have raised concerns about post-surgery weight gain and risk for obesity.
Read MoreA sleep physician identifies alternative metrics for the assessment of the severity of obstructive sleep apnea.
Read MoreLock socket, a solution for securing electrical cords, provides enhanced power protection for various devices, including CPAP machines.
Read MoreThe co-CEOs will succeed Neil Verdal-Austin, who advised the board of his resignation after serving the company for 15 years.
Read MoreAxsome Therapeutics prepares to read out a phase 3 trial for narcolepsy drug candidate AXS-12 and initiate a new pivotal trial for solriamfetol in shift work disorder this quarter.
Read Morestablished by a University of Michigan sleep epidemiologist, the new sleep medicine service aims to combat sleep disorders and help reduce poor health outcomes.
Read MoreThe company’s manufacturer says the FDA-cleared device is also being offered at over 800 sleep clinics as an alternative to CPAP.
Read MoreResearchers say the findings propose that modifying diet might be beneficial in managing or avoiding obstructive sleep apnea.
Read MoreThe acquisition allows Sunrise to offer not only sleep diagnostics but also treat sleep issues.
Read MorePulse oximeters risk inaccuracy in patients with dark skin, leading to potential missed sleep apnea diagnoses. Some pulse ox manufacturers explore more inclusive testing.
Read More